Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Quitkin, F. M. Articles by Klein, D. F. Search for Related Content PubMed Citation Articles by Quitkin, F. M. Articles by Klein, D. F. Antidepressants

Validity of Clinical Trials of Antidepressants

OBJECTIVE: Recent reports have criticized the design of antidepressant studies and have questioned their validity. These critics have concluded that antidepressants are no better than placebo treatment and that their illusory superiority depends on methodologically flawed studies and biased clinical evaluations. It has been suggested that the blind in randomized trials is penetrable—since clinician’s guesses exceed chance—and that only active placebo can appropriately camouflage the difference between drug and placebo response. Furthermore, evidence has been cited to suggest that psychotherapy is as effective as antidepressants in both the acute and maintenance treatment of depression. These positions are often accepted as valid and have been broadly discussed in both the lay press and scientific literature. The purpose of this review is to reassess the cited data that support these assertions. METHOD: The authors examined the specific studies that were cited in these reports, evaluated their methodology, and conducted aggregate analyses. RESULTS: Analyses of the original sources failed to substantiate 1) that standard antidepressants are no more effective than placebo, 2) that active placebo offers an advantage over inactive placebo, or 3) that substantial evidence of a medication bias is suggested by raters’ treatment guesses exceeding chance. The authors also note that some researchers have suggested that the interpretation of psychotherapy trials can be complicated by "allegiance effects." CONCLUSIONS: The issue of bias or allegiance effects for both antidepressant and psychotherapy research is real. Investigators of all orientations must guard against potential bias. However, studies cited as supporting the questionable validity of antidepressant trials fail upon closer examination to support assertions that these trials are invalid.

This article has been cited by other articles:

				F. Alam Effectiveness of cognitive-behavioural intervention by mental health nurses in schizophrenia The British Journal of Psychiatry, March 1, 2007; 190(3): 271 - 271. [Full Text] [PDF]

				F. Benedetti, H. S. Mayberg, T. D. Wager, C. S. Stohler, and J.-K. Zubieta Neurobiological Mechanisms of the Placebo Effect J. Neurosci., November 9, 2005; 25(45): 10390 - 10402. [Full Text] [PDF]

				B. Arias, R. Catalan, C. Gasto, B. Gutierrez, and L. Fananas Evidence for a combined genetic effect of the 5-HT1A receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram J Psychopharmacol, March 1, 2005; 19(2): 166 - 172. [Abstract] [PDF]

				J. H. Meyer, A. A. Wilson, S. Sagrati, D. Hussey, A. Carella, W. Z. Potter, N. Ginovart, E. P. Spencer, A. Cheok, and S. Houle Serotonin Transporter Occupancy of Five Selective Serotonin Reuptake Inhibitors at Different Doses: An [11C]DASB Positron Emission Tomography Study Am J Psychiatry, May 1, 2004; 161(5): 826 - 835. [Abstract] [Full Text] [PDF]

				H. S. Mayberg, J. A. Silva, S. K. Brannan, J. L. Tekell, R. K. Mahurin, S. McGinnis, and P. A. Jerabek The Functional Neuroanatomy of the Placebo Effect Am J Psychiatry, May 1, 2002; 159(5): 728 - 737. [Abstract] [Full Text] [PDF]

				D. F. Klein, M. E. Thase, J. Endicott, L. Adler, I. Glick, A. Kalali, S. Leventer, J. Mattes, P. Ross, and A. Bystritsky Improving Clinical Trials: American Society of Clinical Psychopharmacology Recommendations Arch Gen Psychiatry, March 1, 2002; 59(3): 272 - 278. [Abstract] [Full Text] [PDF]

				J. MONCRIEFF The antidepressant debate The British Journal of Psychiatry, March 1, 2002; 180(3): 193 - 194. [Full Text] [PDF]

				D. V. FORREST The Undiscovered Mind: How the Human Brain Defies Replication, Medication, and Explanation Am J Psychiatry, February 1, 2002; 159(2): 333 - 334. [Full Text] [PDF]

				J. M. Cott, N. Rosenthal, M. Blumenthal, C. M. Fomous, J. H. Cardellina II, H. W. Cohen, P. R. Marantz, R. Brenner, S. Madhusoodanan, M. Pawlowska, et al. St John's Wort and Major Depression JAMA, July 4, 2001; 286(1): 42 - 45. [Full Text] [PDF]

				J. T. Walkup, M. J. Labellarte, M. A. Riddle, D. S. Pine, L. Greenhill, R. Klein, M. Davies, M. Sweeney, H. Abikoff, S. Hack, et al. Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents N. Engl. J. Med., April 26, 2001; 344(17): 1279 - 1285. [Abstract] [Full Text] [PDF]

				A. H. YOUNG Recurrent unipolar depression requires prolonged treatment The British Journal of Psychiatry, April 1, 2001; 178(4): 294 - 295. [Full Text] [PDF]

				T. W. Croghan The Controversy Of Increased Spending For Antidepressants Health Aff., March 1, 2001; 20(2): 129 - 135. [Full Text] [PDF]

				G. ANDREWS Placebo response in depression: bane of research, boon to therapy The British Journal of Psychiatry, March 1, 2001; 178(3): 192 - 194. [Full Text] [PDF]

				R. T. Rubin, D. F. Umanoff, J. M. Veijola, B. L. Duncan, S. D. Miller, M. B. Keller, D. N. Klein, and M. E. Thase Nefazodone, Psychotherapy, and Their Combination for Chronic Depression N. Engl. J. Med., October 5, 2000; 343(14): 1041 - 1043. [Full Text]

				Antidepressants Do Work Journal Watch Women's Health, May 1, 2000; 2000(501): 13 - 13. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 2000 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us